• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Future Information Technology Tools for Fighting Substandard and Falsified Medicines in Low- and Middle-Income Countries.低收入和中等收入国家打击劣质和假药的未来信息技术工具
Front Pharmacol. 2018 Aug 31;9:995. doi: 10.3389/fphar.2018.00995. eCollection 2018.
2
Fighting trafficking of falsified and substandard medicinal products in Russia.打击俄罗斯假药和劣药的非法交易。
Int J Risk Saf Med. 2015;27 Suppl 1:S37-40. doi: 10.3233/JRS-150681.
3
Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.非洲和亚洲的地方组织使用低成本的全球公共卫生实验室微量实验室对假药和劣药进行监测。
PLoS One. 2017 Sep 6;12(9):e0184165. doi: 10.1371/journal.pone.0184165. eCollection 2017.
4
Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.中低收入国家不合格和假冒药品的流行情况及经济负担估计:系统评价和荟萃分析。
JAMA Netw Open. 2018 Aug 3;1(4):e181662. doi: 10.1001/jamanetworkopen.2018.1662.
5
Tackling the global impact of substandard and falsified and unregistered/unlicensed anti-tuberculosis medicines.应对不合格、伪造及未注册/未获许可的抗结核药品的全球影响。
J Med Access. 2022 Jan 23;6:23992026211070406. doi: 10.1177/23992026211070406. eCollection 2022 Jan-Dec.
6
Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance.伪劣药品:案例发现和哨点监测的建议方法。
JMIR Public Health Surveill. 2021 Aug 16;7(8):e29309. doi: 10.2196/29309.
7
Research on the Development of Methods for Detection of Substandard and Falsified Medicines by Clarifying Their Pharmaceutical Characteristics Using Modern Technology.运用现代技术厘清药品特征以研究劣药假药检测方法的开发
Biol Pharm Bull. 2024;47(5):878-885. doi: 10.1248/bpb.b23-00749.
8
Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study.比较检测劣质和假冒阿莫西林技术的投资回报率:肯尼亚案例研究。
PLoS One. 2023 Jan 18;18(1):e0268661. doi: 10.1371/journal.pone.0268661. eCollection 2023.
9
Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.防范假药的公共卫生干预措施:对国际、国家和地方政策的系统评价
Health Policy Plan. 2016 Dec;31(10):1448-1466. doi: 10.1093/heapol/czw062. Epub 2016 Jun 16.
10
Technologies for detecting falsified and substandard drugs in low and middle-income countries.中低收入国家假药和不合格药品的检测技术。
PLoS One. 2014 Mar 26;9(3):e90601. doi: 10.1371/journal.pone.0090601. eCollection 2014.

引用本文的文献

1
Economic barriers to prevent the smuggling of health goods in Iran.伊朗防止卫生用品走私的经济壁垒。
BMJ Glob Health. 2024 Jun 5;9(6):e015090. doi: 10.1136/bmjgh-2024-015090.
2
Tackling the global impact of substandard and falsified and unregistered/unlicensed anti-tuberculosis medicines.应对不合格、伪造及未注册/未获许可的抗结核药品的全球影响。
J Med Access. 2022 Jan 23;6:23992026211070406. doi: 10.1177/23992026211070406. eCollection 2022 Jan-Dec.
3
An open-source smartphone app for the quantitative evaluation of thin-layer chromatographic analyses in medicine quality screening.用于医学质量筛选中薄层色谱分析的定量评估的开源智能手机应用程序。
Sci Rep. 2022 Aug 4;12(1):13433. doi: 10.1038/s41598-022-17527-y.
4
Augmenting Product Defect Surveillance Through Web Crawling and Machine Learning in Singapore.通过网络爬虫和机器学习增强新加坡产品缺陷监测
Drug Saf. 2021 Sep;44(9):939-948. doi: 10.1007/s40264-021-01084-w. Epub 2021 Jun 19.
5
Implementing pharmaceutical track-and-trace systems: a realist review.实施药品追踪系统:一项现实主义综述。
BMJ Glob Health. 2021 May;6(Suppl 3). doi: 10.1136/bmjgh-2020-003755.
6
Mobile apps for detecting falsified and substandard drugs: A systematic review.移动应用程序用于检测假药和劣药:系统评价。
PLoS One. 2021 Feb 4;16(2):e0246061. doi: 10.1371/journal.pone.0246061. eCollection 2021.
7
Tackling the blind spot of poor-quality medicines in Universal Health Coverage.解决全民健康覆盖中劣质药品的盲点问题。
J Pharm Policy Pract. 2020 May 11;13:40. doi: 10.1186/s40545-020-00208-4. eCollection 2020.
8
Unintended Consequences and Hidden Obstacles in Medicine Access in Sub-Saharan Africa.撒哈拉以南非洲地区医疗服务获取中的意外后果与潜在障碍
Front Public Health. 2019 Nov 15;7:342. doi: 10.3389/fpubh.2019.00342. eCollection 2019.
9
Regulatory framework in Pakistan: situation analysis of medicine quality and future recommendations.巴基斯坦的监管框架:药品质量状况分析及未来建议
J Pharm Policy Pract. 2019 Sep 11;12:23. doi: 10.1186/s40545-019-0184-z. eCollection 2019.

本文引用的文献

1
Counterfeit drugs and medical devices in developing countries.发展中国家的假冒药品和医疗器械。
Res Rep Trop Med. 2014 Apr 24;5:11-22. doi: 10.2147/RRTM.S39354. eCollection 2014.
2
Medicine authentication technology as a counterfeit medicine-detection tool: a Delphi method study to establish expert opinion on manual medicine authentication technology in secondary care.药品鉴定技术作为一种假药检测工具:一项德尔菲法研究,旨在就二级医疗中的手工药品鉴定技术确立专家意见。
BMJ Open. 2017 May 6;7(5):e013838. doi: 10.1136/bmjopen-2016-013838.
3
A review of existing and emerging digital technologies to combat the global trade in fake medicines.应对假药全球贸易的现有及新兴数字技术综述。
Expert Opin Drug Saf. 2017 May;16(5):587-602. doi: 10.1080/14740338.2017.1313227. Epub 2017 Apr 7.
4
Quantitative bioassay to identify antimicrobial drugs through drug interaction fingerprint analysis.定量生物测定法通过药物相互作用指纹分析来识别抗菌药物。
Sci Rep. 2017 Feb 16;7:42644. doi: 10.1038/srep42644.
5
Assessment of the effectiveness of the CD3+ tool to detect counterfeit and substandard anti-malarials.评估CD3+工具检测假冒和不合格抗疟药物的有效性。
Malar J. 2016 Feb 25;15:119. doi: 10.1186/s12936-016-1180-2.
6
Quality of the antibiotics--amoxicillin and co-trimoxazole from Ghana, Nigeria, and the United Kingdom.来自加纳、尼日利亚和英国的抗生素——阿莫西林和复方新诺明的质量。
Am J Trop Med Hyg. 2015 Jun;92(6 Suppl):87-94. doi: 10.4269/ajtmh.14-0539. Epub 2015 Apr 20.
7
Development of simplified HPLC methods for the detection of counterfeit antimalarials in resource-restraint environments.开发用于在资源受限环境中检测假冒抗疟药物的简化高效液相色谱法。
J Pharm Biomed Anal. 2014 Sep;98:434-45. doi: 10.1016/j.jpba.2014.06.013. Epub 2014 Jun 16.
8
Technologies for detecting falsified and substandard drugs in low and middle-income countries.中低收入国家假药和不合格药品的检测技术。
PLoS One. 2014 Mar 26;9(3):e90601. doi: 10.1371/journal.pone.0090601. eCollection 2014.
9
Local health workers' perceptions of substandard care in the management of obstetric hemorrhage in rural Malawi.当地卫生工作者对马拉维农村地区产科出血管理中不达标护理的看法。
BMC Pregnancy Childbirth. 2013 Feb 15;13:39. doi: 10.1186/1471-2393-13-39.

低收入和中等收入国家打击劣质和假药的未来信息技术工具

Future Information Technology Tools for Fighting Substandard and Falsified Medicines in Low- and Middle-Income Countries.

作者信息

Rasheed Huma, Höllein Ludwig, Holzgrabe Ulrike

机构信息

Institute of Pharmacy and Food Chemistry, University of Wuerzburg, Wuerzburg, Germany.

Institute of Pharmaceutical Sciences, University of Veterinary and Animal Sciences, Lahore, Pakistan.

出版信息

Front Pharmacol. 2018 Aug 31;9:995. doi: 10.3389/fphar.2018.00995. eCollection 2018.

DOI:10.3389/fphar.2018.00995
PMID:30233373
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6127459/
Abstract

Substandard and falsified (SF) medicines have emerged as a global public health issue within the last two decades especially in low- and middle-income countries (LMICs). Serious consequences of this problem include a loss of trust and increased financial costs due to less disease control and more frequent complications during therapy. Of note, antimicrobial resistance is an additional long-term implication of poor-quality antimicrobials. This review covers information technology tools including medicines authentication tools (MAT) as mobile apps and messaging service, 2D barcoding approaches with drug safety alert systems, web based drug safety alerts, radiofrequency identification tags, databases to support visual inspection, digital aids to enhance the performance of quality evaluation kits, reference libraries for identification of falsified and substandard medicines, and quality evaluation kits based on machine learning for field testing. While being easy to access and simple to use, these initiatives are gaining acceptance in LMICs. Implementing 2D barcoding based on end-to-end verification and "Track and Trace" systems has emerged as a step toward global security in the supply chain. A breakthrough in web-based drug safety alert systems and data bases was the establishment of the Global Surveillance and Monitoring System by the World Health Organization in 2013. Future applications include concepts including "lab on a chip" and "paper analytical devices" and are claimed to be convenient and simple to use as well as affordable. The principles discussed herein are making profound impact in the fight against substandard and falsified medicines, offering cheap and accessible solutions.

摘要

在过去二十年中,不合格和伪造药品已成为一个全球公共卫生问题,尤其在低收入和中等收入国家。这一问题的严重后果包括信任丧失以及因治疗期间疾病控制不佳和并发症频发导致的财务成本增加。值得注意的是,抗菌药物耐药性是劣质抗菌药物带来的另一个长期影响。本综述涵盖了信息技术工具,包括作为移动应用程序和消息服务的药品认证工具(MAT)、带有药品安全警报系统的二维条形码方法、基于网络的药品安全警报、射频识别标签、支持目视检查的数据库、增强质量评估试剂盒性能的数字辅助工具、用于识别伪造和不合格药品的参考库以及基于机器学习的现场测试质量评估试剂盒。这些举措易于获取且使用简单,在低收入和中等收入国家正逐渐得到认可。实施基于端到端验证和“追踪溯源”系统的二维条形码已成为迈向全球供应链安全的一步。基于网络的药品安全警报系统和数据库的一个突破是世界卫生组织于2013年建立了全球监测系统。未来的应用包括“芯片实验室”和“纸质分析设备”等概念,据称这些概念使用方便、简单且价格低廉。本文讨论的原则正在对打击不合格和伪造药品的斗争产生深远影响,提供了廉价且易于获取的解决方案。